Passionflower for Anxiety: What the Evidence Shows

Passionflower — Passiflora incarnata — is one of the oldest herbal sedatives, sold as tea, tincture, and capsule for nerves, racing thoughts, and restless sleep.

Here’s the honest version. Passionflower has some of the more interesting small-trial signals in the calming-herb category: one head-to-head study put it level with a benzodiazepine for generalized anxiety, and several controlled trials show it blunts pre-surgery nerves. But the evidence base is tiny — a handful of small trials, different preparations in each — and when the Cochrane collaboration pooled it, they found too few studies to draw any conclusion at all. It’s a plausible, low-risk short-term option. It is not a proven anxiety treatment.

Does passionflower work for anxiety?

The most striking data point is also the smallest, and it’s worth reading carefully.

A 2001 double-blind RCT (Akhondzadeh et al.) in the Journal of Clinical Pharmacy and Therapeutics randomized 36 outpatients with DSM-IV generalized anxiety disorder to either passionflower extract (45 drops/day) or the benzodiazepine oxazepam (30 mg/day) for 4 weeks. Both treatments worked, and — the headline finding — there was no significant difference between them at the end of the trial. Oxazepam kicked in faster in the first few days. But the passionflower group had significantly fewer problems with impairment of job performance, the sedation-and-fogginess tax that benzodiazepines charge.

That’s a genuinely notable result: an herb performing comparably to a prescription anxiolytic, with less daytime impairment. Keep the scale in mind though — 36 people, 4 weeks, one small pilot. The authors themselves called it a pilot and said a large-scale trial was justified.

Is there any more controlled evidence?

Yes — and it comes from an unusual place: the operating room. Pre-surgery anxiety is one of the few settings where you can run a clean, blinded, placebo-controlled test of an acute anxiolytic, because you have a defined stressor and objective outcomes.

A 2008 double-blind RCT (Movafegh et al.) in Anesthesia & Analgesia gave 60 ambulatory surgery patients either 500 mg of oral Passiflora incarnata or placebo 90 minutes before their operation. The passionflower group had significantly lower anxiety scores than placebo — and, importantly, without added sedation and without slowing psychomotor recovery or discharge. That last part matters: it’s the same low-impairment profile the GAD trial hinted at.

This is arguably the most controlled evidence passionflower has, and it’s the part most supplement blogs skip in favor of the flashier benzodiazepine comparison. It’s a real placebo-controlled signal — for acute, situational anxiety.

Then why do reviewers say the evidence is weak?

Because when experts pooled the anxiety trials, there was almost nothing to pool.

The 2007 Cochrane systematic review (Miyasaka et al.) set out to assess passionflower for anxiety disorders and found only two eligible RCTs, with 198 participants total. One suggested passionflower and benzodiazepines were similarly effective; there were hints of better job performance and less drowsiness with passionflower, but neither reached statistical significance. The reviewers’ verdict was blunt: the trials are “too few in number to permit any conclusions to be drawn,” and larger studies comparing passionflower with placebo and other medications are needed.

That’s the information most marketing pages leave out. “Comparable to a benzodiazepine” sounds definitive; “the world’s most rigorous evidence review couldn’t reach a conclusion” is the necessary asterisk. Both are true, and you need both to calibrate. It’s the same evidence-quality ceiling you hit across the anxiety supplement literature: promising direction, sample sizes too small to trust.

What about sleep and the newer dental trials?

The sleep signal is real but modest. A 2011 double-blind, placebo-controlled crossover trial (Ngan & Conduit) in Phytotherapy Research had 41 healthy adults drink passionflower tea or placebo tea for a week each. Of six sleep-diary measures, only subjective sleep quality came out significantly better on passionflower (p < 0.01) — a real but narrow win, in people with only mild sleep fluctuations. That overlap between calming and sleep signals is common across herbs used for both anxiety and sleep.

The newest evidence adds a useful caution. A 2025 RCT (Lima Neto et al.) in Scientific Reports compared Passiflora, midazolam, and placebo in 30 patients undergoing third-molar extraction. Here passionflower did not beat placebo on subjective anxiety scores — but it did lower biochemical stress markers (salivary cortisol and α-amylase). So the picture isn’t uniformly positive: sometimes the felt effect and the measured physiology don’t line up, and small trials produce mixed results depending on how you measure.

So should you try it?

For short-term, situational anxiety, passionflower is a low-risk thing to test. Across these trials it was well tolerated, non-sedating at the doses studied, and — in the GAD pilot — easier on daytime function than a benzodiazepine. That’s a reasonable risk profile for a brief trial.

Just size your expectations to the evidence, not the marketing. The realistic claim is: a plausible, gentle nudge for acute nerves and sleep quality, supported by a few small trials and undercut by a Cochrane review that couldn’t conclude anything. It is not established treatment for a diagnosed anxiety disorder — if that’s what you’re dealing with, it’s a conversation with a clinician, not a supplement aisle. And an herb won’t retrain a nervous system that’s stuck in a chronic threat response; the drivers of anxiety regulation run deeper than any single capsule.

For the bigger picture on non-drug tools for a dysregulated nervous system, see the pillar guide on anxiety regulation and sleep restoration.